Characterizing causal relationships of visceral fat and body shape on multiple sclerosis risk.

Elina Misicka, Douglas Gunzler, Jeffrey Albert, Farren B S Briggs
Author Information
  1. Elina Misicka: Department of Population and Quantitative Health Sciences, Case Western Reserve University School of Medicine, Cleveland, OH, USA.
  2. Douglas Gunzler: Department of Population and Quantitative Health Sciences, Case Western Reserve University School of Medicine, Cleveland, OH, USA; Center for Health Care Research and Policy, Case Western Reserve School of Medicine, Cleveland, OH, USA.
  3. Jeffrey Albert: Department of Population and Quantitative Health Sciences, Case Western Reserve University School of Medicine, Cleveland, OH, USA.
  4. Farren B S Briggs: Department of Public Health Sciences, University of Miami Miller School of Medicine, Miami, FL, USA. Electronic address: fbb31@miami.edu.

Abstract

BACKGROUND: Epidemiologic studies have established obesity as a risk factor for multiple sclerosis (MS). These studies relied on body-mass index (BMI) and body size silhouettes as the primary measures of obesity. Unfortunately, the causal mechanisms through which obesity confers MS risk are not yet known.
OBJECTIVES: To investigate the causal effects of multiple specific measures of body fat on MS risk in populations of European descent, using Mendelian randomization (MR).
METHODS: MR is a genetic instrumental variable analysis utilizing genome-wide association (GWA) summary statistics to infer causality between phenotypes. MR analyses were performed to investigate the relationships between seven measures of body fat (BMI, waist-hip ratio, visceral adipose tissue [VAT], subcutaneous adipose tissue, and arm-, leg-, and trunk-fat to total body fat ratio) and MS risk.
RESULTS: Only BMI and VAT were significantly associated with MS risk in separate MR analyses (β=0.27, p<0.001; β=0.28, p=0.006). High correlation between BMI and VAT instruments suggest that two-sample MR associations for BMI and VAT likely capture the same causal mechanisms.
CONCLUSIONS: BMI and VAT were causally associated with MS risk in European populations, though their effects do not appear independent, suggesting overlap in the role of overall body mass and visceral obesity in MS pathogenesis.

Keywords

References

  1. Mult Scler. 2017 Oct;23(11):1461-1468 [PMID: 27903934]
  2. Nat Med. 2019 Sep;25(9):1390-1395 [PMID: 31501611]
  3. Hum Mol Genet. 2018 Oct 15;27(20):3641-3649 [PMID: 30124842]
  4. Neurol Neuroimmunol Neuroinflamm. 2020 Jan 14;7(2): [PMID: 31937597]
  5. Mult Scler. 2013 Sep;19(10):1323-9 [PMID: 23549432]
  6. Diabetologia. 2003 Dec;46(12):1604-10 [PMID: 14595538]
  7. Am J Epidemiol. 2015 Feb 15;181(4):251-60 [PMID: 25632051]
  8. Mult Scler. 2022 Oct;28(11):1673-1684 [PMID: 35575213]
  9. Cell. 2007 Oct 19;131(2):242-56 [PMID: 17956727]
  10. J Lipid Res. 2019 Oct;60(10):1710-1719 [PMID: 30097511]
  11. PLoS Med. 2016 Jun 28;13(6):e1002053 [PMID: 27351487]
  12. Front Cardiovasc Med. 2020 Feb 25;7:22 [PMID: 32158768]
  13. Nat Commun. 2019 Jan 21;10(1):339 [PMID: 30664634]
  14. Mult Scler. 2021 Nov;27(13):1994-2000 [PMID: 33605807]
  15. Diabet Med. 2007 Feb;24(2):166-71 [PMID: 17257279]
  16. Neurology. 2009 Nov 10;73(19):1543-50 [PMID: 19901245]
  17. Eur J Epidemiol. 2017 May;32(5):377-389 [PMID: 28527048]
  18. Adv Exp Med Biol. 2017;1043:9-27 [PMID: 29224088]
  19. Ageing Res Rev. 2009 Oct;8(4):339-48 [PMID: 19576300]
  20. J Neurol Neurosurg Psychiatry. 2016 Feb;87(2):181-7 [PMID: 25722366]
  21. Mult Scler. 2015 Apr;21(4):388-95 [PMID: 25182290]
  22. Auto Immun Highlights. 2019 Aug 10;10(1):7 [PMID: 32257063]
  23. Nat Genet. 2018 May;50(5):693-698 [PMID: 29686387]
  24. Mult Scler. 2021 Jan;27(1):160-161 [PMID: 32662727]
  25. Arch Med Sci. 2017 Jun;13(4):851-863 [PMID: 28721154]
  26. Obes Res Clin Pract. 2014 Sep-Oct;8(5):e435-47 [PMID: 25263833]
  27. J Neurol. 2020 Oct;267(10):3083-3091 [PMID: 32529581]
  28. Science. 2019 Sep 27;365(6460): [PMID: 31604244]
  29. Int J Biochem Cell Biol. 2017 Dec;93:148-155 [PMID: 28720279]
  30. Elife. 2021 Jun 15;10: [PMID: 34128465]
  31. Ageing Res Rev. 2021 Nov;71:101445 [PMID: 34391946]
  32. Am J Epidemiol. 2017 Feb 1;185(3):162-171 [PMID: 28073764]
  33. Mult Scler. 2021 Dec;27(14):2150-2158 [PMID: 33749377]
  34. Lancet Diabetes Endocrinol. 2014 Nov;2(11):901-10 [PMID: 24731669]
  35. Eur J Neurol. 2019 Jan;26(1):87-e8 [PMID: 30103277]
  36. Cold Spring Harb Perspect Med. 2018 Sep 4;8(9): [PMID: 29358317]
  37. Hum Mol Genet. 2019 Jan 1;28(1):166-174 [PMID: 30239722]
  38. Hum Mol Genet. 2018 Aug 1;27(R2):R195-R208 [PMID: 29771313]
  39. Nature. 2015 Feb 12;518(7538):197-206 [PMID: 25673413]

Grants

  1. T32 HL007567/NHLBI NIH HHS

MeSH Term

Humans
Intra-Abdominal Fat
Somatotypes
Genome-Wide Association Study
Multiple Sclerosis
Obesity
Body Mass Index
Polymorphism, Single Nucleotide

Word Cloud

Created with Highcharts 10.0.0riskMSBMIbodyfatMRobesitycausalVATmultiplesclerosismeasuresvisceralstudiesmechanismsinvestigateeffectspopulationsEuropeanMendelianrandomizationanalysesrelationshipsratioadiposetissueassociatedβ=0BACKGROUND:Epidemiologicestablishedfactorreliedbody-massindexsizesilhouettesprimaryUnfortunatelyconfersyetknownOBJECTIVES:specificdescentusingMETHODS:geneticinstrumentalvariableanalysisutilizinggenome-wideassociationGWAsummarystatisticsinfercausalityphenotypesperformedsevenwaist-hip[VAT]subcutaneousarm-leg-trunk-fattotalRESULTS:significantlyseparate27p<000128p=0006Highcorrelationinstrumentssuggesttwo-sampleassociationslikelycaptureCONCLUSIONS:causallythoughappearindependentsuggestingoverlaproleoverallmasspathogenesisCharacterizingshapeBodyMultipleRisk

Similar Articles

Cited By